SCHEMBL31268854

SCHEMBL31268854

Cc1ccnc(Cn2c(-c3ccc(OC[C@H]4CCCN4)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHRNA3 P32297 2/20 0.35
▸ LTA4H P09960 1/20 0.33
▸ KCNH2 Q12809 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ PRKCZ Q05513 1/20 0.32
▸ CHRNB2 P17787 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32
▸ PIK3CD O00329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983400 0.89 LTA4H (0.40) CHRNA3LTA4HPRKAB2PRKAG1PRKAA2
SCHEMBL31268903 0.88 KCNH2 (0.34) KCNH2SCN5ASCN9APRKAB2PRKAG1
SCHEMBL31269436 0.87 CHRNA3 (0.36) CHRNA3LTA4HPRKAB2PRKAG1PRKAA2
SCHEMBL31269086 0.85 PDE2A (0.33) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31268847 0.85 KCNH2 (0.36) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31268925 0.85 KCNH2 (0.38) KCNH2SCN5ASCN9APIK3CD
SCHEMBL30983375 0.85 PDE2A (0.35) KCNH2SCN5ASCN9APIK3CD
SCHEMBL30983386 0.84 PIK3CD (0.38) CHRNA3LTA4HCHRNB2CHRNA4PIK3CD
SCHEMBL31268950 0.84 KCNH2 (0.32) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31269380 0.84 PDE2A (0.38) KCNH2SCN5ASCN9APIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback